Enhanced homology-directed human genome engineering by controlled timing of CRISPR/Cas9 delivery
The CRISPR/Cas9 system is a robust genome editing technology that works in human cells, animals and plants based on the RNA-programmed DNA cleaving activity of the Cas9 enzyme. Building on previous work (Jinek et al., 2013), we show here that new genetic information can be introduced site-specifical...
Main Authors: | Steven Lin, Brett T Staahl, Ravi K Alla, Jennifer A Doudna |
---|---|
Format: | Article |
Language: | English |
Published: |
eLife Sciences Publications Ltd
2014-12-01
|
Series: | eLife |
Subjects: | |
Online Access: | https://elifesciences.org/articles/04766 |
Similar Items
-
A high-throughput small molecule screen identifies farrerol as a potentiator of CRISPR/Cas9-mediated genome editing
by: Weina Zhang, et al.
Published: (2020-07-01) -
Potential Roles of the Retinoblastoma Protein in Regulating Genome Editing
by: Yuning Jiang, et al.
Published: (2018-07-01) -
CRISPR-sub: Analysis of DNA substitution mutations caused by CRISPR-Cas9 in human cells
by: Gue-Ho Hwang, et al.
Published: (2020-01-01) -
Removal of extra sequences with I-SceI in combination with CRISPR/Cas9 technique for precise gene editing in Drosophila
by: Nikolay Zolotarev, et al.
Published: (2019-04-01) -
A Novel Breakthrough in Leptospira spp. Mutagenesis: Knockout by Combination of CRISPR/Cas9 and Non-homologous End-Joining Systems
by: Luis G. V. Fernandes, et al.
Published: (2022-05-01)